Publications

Strohmeier V, Andrieux G, Unger S, Pascual-Reguant A, Klocperk A, Seidl M, Marques OC, Eckert M, Gräwe K, Shabani M, von Spee-Mayer C, Friedmann D, Harder I, Gutenberger S, Keller B, Proietti M, Bulashevska A, Grimbacher B, Provaznik J, Benes V, Goldacker S, Schell C, Hauser AE, Boerries M, Hasselblatt P, Warnatz K. 2023. Interferon-Driven Immune Dysregulation in Common Variable Immunodeficiency-Associated Villous Atrophy and Norovirus Infection. J Clin Immunol. 43(2):371-390. doi: 10.1007/s10875-022-01379-2.

Kemna J, Gout E, Daniau L, Lao J, Weißert K, Ammann S, Kühn R, Richter M, Molenda C, Sporbert A, Zocholl D, Klopfleisch R, Lortat-Jacob H, Aichele P, Kammertoens T, Blankenstein T. 2023. IFNγ binding to extracellular matrix prevents fatal systemic toxicity. Nat Immunol. 24, 414–422. doi.org/10.1038/s41590-023-01420-5

Griewahn L, Müller-Foxworth M, Peintner L, Wissler M, Weiss M, Brauns-Schubert P, Massoumi R, Borner C, Groß O, Yabal M, Charvet C, Maurer U. 2023. SPATA2 restricts OTULIN-dependent LUBAC activity independently of CYLD. Cell Rep. 42(1):111961. doi: 10.1016/j.celrep.2022.111961.

Thelen B, Schipperges V, Knörlein P, Hummel JF, Arnold F, Kupferschmid L, Klose CSN, Arnold SJ, Boerries M, Tanriver Y. 2023. Eomes is sufficient to regulate IL-10 expression and cytotoxic effector molecules in murine CD4+ T cells. Front Immunol. 2023 Jan 19;14:1058267. doi: 10.3389/fimmu.2023.1058267.

Antón-García P, Haghighi EB, Rose K, Vladimirov G, Boerries M, Hecht A. 2023. TGFβ1-Induced EMT in the MCF10A Mammary Epithelial Cell Line Model Is Executed Independently of SNAIL1 and ZEB1 but Relies on JUNB-Coordinated Transcriptional Regulation. Cancers (Basel). 2023 Jan 16;15(2):558. doi: 10.3390/cancers15020558.

Zink A, Zenke S, Wiese T, Beyersdorf N, Lämmermann T, Rohr JC. 2023. Analyzing trogocytosis of T lymphocytes by flow cytometry and confocal microscopy. STAR Protoc. Jan 11;4(1):102013. doi: 10.1016/j.xpro.2022.102013.

Maccari ME, Schneider P, Smulski CR, Meinhardt A, Pinto F, Gonzalez-Granado LI, Schuetz C, Sica MP, Gross M, Fuchs I, Kury P, Heeg M, Vocat T, Willen L, Thomas C, Hühn R, Magerus A, Lorenz M, Schwarz K, Rieux-Laucat F, Ehl S, Rensing-Ehl A. Revisiting autoimmune lymphoproliferative syndrome caused by Fas ligand mutations. J Allergy Clin Immunol. 2023 Jan 5:S0091-6749(23)00001-5. doi: 10.1016/j.jaci.2022.11.028.

van Otterdijk, S. D., H. Klett, M. Boerries, and K. B. Michels. 2023. The impact of pre-pregnancy folic acid intake on placental DNA methylation in a fortified cohort. FASEB J 37: e22698. doi: 10.1096/fj.202200476RR.

Rapp, J., M. Jung, R. F. U. Klar, J. Wolf, J. Arnold, O. Gorka, O. Gross, C. Lange, H. Agostini, G. Schlunck, and F. Bucher. 2022. STAT3 signaling induced by IL-6 family cytokines modulates angiogenesis. J Cell Sci. :jcs.260182. doi: 10.1242/jcs.260182.

Ruckert, T., G. Andrieux, M. Boerries, K. Hanke-Muller, N. M. Woessner, S. Doetsch, C. Schell, K. Aumann, J. Kolter, A. Schmitt-Graeff, M. Schiff, L. M. Braun, E. Haring, S. Kissel, B. A. Siranosian, A. S. Bhatt, P. Nordkild, J. Wehkamp, B. A. H. Jensen, S. Minguet, J. Duyster, R. Zeiser, and N. Kohler. 2022. Human beta-defensin 2 ameliorates acute GVHD by limiting ileal neutrophil infiltration and restraining T cell receptor signaling. Sci Transl Med 14: eabp9675. doi: 10.1126/scitranslmed.abp9675.

Rush-Kittle, J., L. Gamez-Diaz, and B. Grimbacher. 2022. Inborn errors of immunity associated with defects of self-tolerance checkpoints: The CD28 family. Pediatr Allergy Immunol 33: e13886. doi: 10.1111/pai.13886.

Weissert, K., S. Ammann, T. Kogl, V. Dettmer-Monaco, C.  Schell, T. Cathomen, S. Ehl, and P. Aichele. 2022. Adoptive T cell therapy cures mice from active hemophagocytic lymphohistiocytosis (HLH). EMBO Mol Med: e16085. doi: 10.15252/emmm.202216085.

Jacobsen, E. M., D. Fabricius, M. Class, F. Topfstedt, R. Lorenzetti, I. Janowska, F. Schmidt, J. Staniek, M. Zernickel, T. Stamminger, A. N. Dietz, A. Zellmer, M. Hecht, P. Rauch, C. Blum, C. Ludwig, B. Jahrsdorfer, H. Schrezenmeier, M. Heeg, B. Mayer, A. Seidel, R. Gross, J. Munch, F. Kirchhoff, S. F. N. Bode, G. Strauss, H. Renk, R. Elling, M. Stich, R.E. Voll, B. Tonshof, A. R. Franz, P. Henneke, K. M. Debatin, M. Rizzi, and A. Janda. 2022. High antibody levels and reduced cellular response in children up to one year after SARS-CoV-2 infection. Nat Commun 13: 7315. doi: 10.1038/s41467-022-35055-1.

Corrales, E., E. Levit-Zerdoun, P. Metzger, R. Mertes, A. Lehmann, J. Munch, S. Lemke, S. Kowar, and M. Boerries. 2022. PI3K/AKT signaling allows for MAPK/ERK pathway independency mediating dedifferentiation-driven treatment resistance in melanoma. Cell Commun Signal 20: 187. doi: 10.1186/s12964-022-00989-y.

Kraemer, A. N., A. L. Schafer, D. T. L. Sprenger, B. Sehnert, J. P. Williams, A. Luo, L. Riechert, Q. Al-Kayyal, H. Dumortier, J. D. Fauny, Z. Winter, K. Heim, M. Hofmann, M. Herrmann, G. Heine, R. E. Voll, and N. Chevalier. 2022. Impact of dietary vitamin D on immunoregulation and disease pathology in lupus-prone NZB/W F1 mice. Front Immunol 13: 933191. doi: 10.3389/fimmu.2022.933191.